+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID07482592

Phase 1 Study of TQB3205 Capsule for Safety and Preliminary Effectiveness in Adults with Advanced Malignant Tumors

Led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Updated on 2026-04-20

156

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating TQB3205 capsules in adults with advanced malignant tumors to assess safety, tolerability, how the drug moves and is processed in the body pharmacokinetics, and early signs of effectiveness. This phase 1 clinical trial uses a single-center, open, non-randomized, single-arm design to study patients with advanced cancer. The study includes two phases dose escalation and dose expansion, aimed at finding the right dosing levels and understanding treatment effects. Participants take TQB3205 capsules orally once a day on an empty stomach, with doses ranging from 6 to 36 mg per administration. Each treatment cycle lasts 21 days. The study includes both single-dose and continuous dosing regimens, with ongoing monitoring for safety and response. The trial seeks to determine dose limiting toxicity, maximum tolerated dose, recommended phase II dose, and maximum assessed dose over the course of treatment. During the trial, participants will undergo regular assessments including monitoring for adverse events and serious adverse events from the first dose until 28 days after the last dose or until starting other anti-tumor treatments, up to about three years. Laboratory tests and pharmacokinetic measurements will be taken at specific time points during each cycle. Outcomes like overall response rate, disease control, progression-free survival, and overall survival will be tracked. The study may last up to 24 months for dose evaluation and up to 100 weeks for survival and disease control outcomes.

CONDITIONS

Brief Title

Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors

Research Team

J

Jihui Hao, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here